Xvivo Perfusion
Price
Price
CHART BY
Frequently asked questions
What is Xvivo Perfusion's market capitalization?
What is Xvivo Perfusion's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Xvivo Perfusion?
What are the analyst ratings and target price for Xvivo Perfusion's stock?
What is Xvivo Perfusion's revenue over the trailing twelve months?
What is the EBITDA for Xvivo Perfusion?
What is the free cash flow of Xvivo Perfusion?
How many employees does Xvivo Perfusion have, and what sector and industry does it belong to?
What is the free float of Xvivo Perfusion's shares?
Financials
- Market Cap
- SEK 8.43B
- EPS (TTM)
- $0.799
- Free Float
- 24.74M
- P/E ratio (TTM)
- 335.00
- Revenue (TTM)
- SEK 812.17M
- EBITDA (TTM)
- SEK 163.23M
- Free Cashflow (TTM)
- SEK 101.07M
Pricing
- 1D span
- $31.42$31.50
- 52W span
- $16.77$34.65
Analyst Ratings
The price target is SEK 328.57 and the stock is covered by 6 analysts.
Buy
6
Hold
0
Sell
0
Information
Xvivo Perfusion AB is a medical technology company operates in the field of organ transplantation technology. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. The company operates through the following segments: Thoracic, Abdominal and Services. The Thoracic segment engages in the sale of products for lung and heart transplantation. The Abdominal segment engages in the sale of products for liver and kidney transplantation. The Services segment engages in providing organ recovery-related services. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden.
- Employees
- 210
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0004840718
- Primary Ticker
- XVIVO